Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis
Stock Information for Lexicon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.